Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1977-08-01
1978-10-31
Rosen, Sam
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
A61K 3902
Patent
active
041235207
ABSTRACT:
A vaccine against Group C meningococcal meningitis consisting of a polysaccharide of which at least 80% by weight has a molecular weight in excess of 1,000,000 daltons is prepared. The polysaccharide was isolated from Group C hexadecyl trimethylammonium bromide cell paste with 1.0M CaCl.sub.2 extraction and purified by phenol extraction, ultracentrifugation at 100,000 g. and ethanol fractionation (30%-45% v/v in ethanol).
REFERENCES:
bhattacharjee et al - Chem. Abst., vol. 84 (1976) p. 134, 003w.
Limjuco et al - Chem. Abst., vol. 85 (1976) p. 175 449k.
Apicella - Chem. Abst., vol. 85 (1976) p. 92 038z.
Zollinger et al - Chem. Abst., vol. 78 (1973) p. 143 65v.
Carlo Dennis J.
Hagopian Arpi
Stoudt Thomas H.
Levitt Julian S.
Merck & Co. , Inc.
Perrella Donald J.
Riedl Edmunde D.
Rosen Sam
LandOfFree
Method for preparing high molecular weight meningococcal Group C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing high molecular weight meningococcal Group C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing high molecular weight meningococcal Group C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1835349